Atrial Fibrillation - Pipeline Review, H2 2015

1
Atrial Fibrillation - Pipeline Review, H2 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Scope
• The report provides a snapshot of the global
  therapeutic landscape of Atrial Fibrillation
• The report reviews key pipeline products under
  drug profile section which includes, product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities
• The report reviews key players involved in the
  therapeutics development for Atrial Fibrillation
  and enlists all their major and minor projects
• The report summarizes all the dormant and
  discontinued pipeline projects
• A review of the Atrial Fibrillation products
  under development by companies and
  universities/research institutes based on
  information derived from company and
  industry-specific sources
• Pipeline products coverage based on various
  stages of development ranging from
  pre-registration till discovery and undisclosed
  stages
• A detailed assessment of monotherapy and
  combination therapy pipeline projects
• Coverage of the Atrial Fibrillation pipeline on
  the basis of target, MoA, route of administration
  and molecule type Latest news and deals relating
  related to pipeline products
• Read More At http//www.researchbeam.com/atrial-
  fibrillation-pipeline-review-h2-2015-market

3


Table of Content
List of Tables 6List of Figures 7Introduction
8Global Markets Direct Report Coverage 8Atrial
Fibrillation Overview 9Therapeutics Development
10Pipeline Products for Atrial Fibrillation -
Overview 10Pipeline Products for Atrial
Fibrillation - Comparative Analysis 11Atrial
Fibrillation - Therapeutics under Development by
Companies 12Atrial Fibrillation - Therapeutics
under Investigation by Universities/Institutes
14Atrial Fibrillation - Pipeline Products Glance
15Late Stage Products 15Clinical Stage Products
16Early Stage Products 17Atrial Fibrillation -
Products under Development by Companies 18Atrial
Fibrillation - Products under Investigation by
Universities/Institutes 20Atrial Fibrillation -
Companies Involved in Therapeutics Development
21ARCA biopharma, Inc. 21Armetheon, Inc.
22AstraZeneca Plc 23
4


Report Overview
Reasons to buy Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage Develop strategic initiatives by
understanding the focus areas of leading
companies Identify and understand important and
diverse types of therapeutics under development
for Atrial Fibrillation Plan mergers and
acquisitions effectively by identifying key
players of the most promising pipeline Devise
corrective measures for pipeline projects by
understanding Atrial Fibrillation pipeline depth
and focus of Indication therapeutics Develop and
design in-licensing and out-licensing strategies
by identifying prospective partners with the most
attractive projects to enhance and expand
business potential and Scope Modify the
therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove
them from pipeline Enquire At
http//www.researchbeam.com/atrial-fibrillation-pi
peline-review-h2-2015-market/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/atrial-fibrillation-pi
peline-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com